Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis

Clinical trial NCT00012467 · COMPLETED

Trial details

NCT number: NCT00012467
Sponsor: InterMune
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Meningitis, Cryptococcal HIV Infections

Start date: 2000-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.